Abattis Bioceuticals Corp. (ATTBF)

[Mr. McCringleberry]

FITX vs ATTBF:

Market Cap - Summary - ATTBF is valued at 30% the value of FITX :

ATTBF $87M --> 55.8M o/s times $1.56 per share (http://www.marketfy.com/product/420investor/blog/815/view/42392/)
FITX - $288M --> 3.4B o/s times $.085 per share (per otcmarkets.com)

Also, heavy further dilution with FITX is likely pending and I understand that the transfer agent is choked for FITX. See link and note that private investors don't just give away their money:

http://www.marketwatch.com/story/creative-edge-nutrition-fitx-announces-private-funding-for-the-build-out-of-the-worlds-largest-and-most-advanced-legal-cannabis-production-facility-2014-03-21

ATTBF CEO has publicly stated target for dilution is no more than 100m shares.

Licenses pursued:

ATTBF - 3 licenses - 1 MMRP license for "Ijuana" subsidiary (unknown quantity) and a controlled substance license for "Northern Vine" subsidiary - this one is for testing marijuana and ATTBF would be the only canadian company with this type of license for marijuana substance. ATTBF's subsidiary Northern Vine also owns 25% equity interest in Experion, a private company, who is currently licensed under MMAR (this means that they can grow and sell marijuana RIGHT NOW while the injunction is in effect) and seeking MMRP license. CEO has stated publicly licensure expected by June.
FITX - 1 MMRP license for 1.3M pounds of marijuana in one geographic location


Licenses held:

ATTBF - MMAR through equity partner Experion
FITX - None

Company Management / insiders:

ATTBF - Mike Withrow - Canadian Pacific Phytoplnkton Ltd., Canadian Pacific Algae Inc, BFuel Canada
FITX - 1) Bill Chaaban - former lawyer. 2) Randy Hamdan (Private investor) - this --> http://www.sec.gov/litigation/complaints/2013/comp22892.pdf

Regulatory filing:

ATTBF - fully audited through canadian exchange. Trades pink sheets in US
FITX - unaudited, pink sheets

Key partnerships:

ATTBF - 1) Equity partner with Experion (private company), 2) Business partner with Phytalab (marijuana testing in Washington state) 3) Business partner with ERBB
FITX - 1) Equity partner with PHOT, 2) Equity partner with RXNB, 3) Unknown private investors with undisclosed equity interest

Technologies:

ATTBF- worldwide rights to "Mass Plant Growing System". Biocube grow pods. -->
http://www.marketfy.com/product/420investor/blog/815/view/42392/
FITX - Unknown. Sam Aleweigh has claimed to have severel undisclosed patents pending relating to growing marijuana. Claims via Facebook to be able to grow 4 Lbs of dried marijuana per plant. Claims via Facebook to have a 30 day turnover in grows for each plant. These claims appear outlandish relative to other growers.

"The Story":
ATTBF - See following link. I will let you judge for yourself:
http://www.marketfy.com/product/420investor/blog/815/view/42392/

FITX - largely unclear. CEO communicates via Facebook without providing substance.

There is so much more but I just don't have time to compile it. Literally every angle I look at these two companies favors ATTBF. How is FITX valued higher?